Molecular Templates Inc (MTEM)
0.4672
-0.14
(-23.41%)
USD |
NASDAQ |
Nov 15, 16:00
0.411
-0.06
(-12.03%)
After-Hours: 20:00
Molecular Templates Enterprise Value: -6.581M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | -6.581M |
| November 14, 2024 | -5.641M |
| November 13, 2024 | -7.536M |
| November 12, 2024 | -7.475M |
| November 11, 2024 | -7.366M |
| November 08, 2024 | -7.301M |
| November 07, 2024 | -7.068M |
| November 06, 2024 | -6.904M |
| November 05, 2024 | -6.907M |
| November 04, 2024 | -6.648M |
| November 01, 2024 | -6.643M |
| October 31, 2024 | -6.694M |
| October 30, 2024 | -6.694M |
| October 29, 2024 | -6.693M |
| October 28, 2024 | -6.363M |
| October 25, 2024 | -5.707M |
| October 24, 2024 | -5.532M |
| October 23, 2024 | -5.260M |
| October 22, 2024 | -5.003M |
| October 21, 2024 | -4.719M |
| October 18, 2024 | -4.719M |
| October 17, 2024 | -3.534M |
| October 16, 2024 | -7.517M |
| October 15, 2024 | -7.432M |
| October 14, 2024 | -7.090M |
| Date | Value |
|---|---|
| October 11, 2024 | 0.0213M |
| October 10, 2024 | 0.0872M |
| October 09, 2024 | -0.0445M |
| October 08, 2024 | -0.3006M |
| October 07, 2024 | -0.1762M |
| October 04, 2024 | -0.0438M |
| October 03, 2024 | -0.3737M |
| October 02, 2024 | -1.032M |
| October 01, 2024 | -0.67M |
| September 30, 2024 | -0.4066M |
| September 27, 2024 | -0.3737M |
| September 26, 2024 | -0.67M |
| September 25, 2024 | -0.7029M |
| September 24, 2024 | -1.295M |
| September 23, 2024 | -1.230M |
| September 20, 2024 | -0.7687M |
| September 19, 2024 | -0.7029M |
| September 18, 2024 | -0.8346M |
| September 17, 2024 | -1.032M |
| September 16, 2024 | -1.032M |
| September 13, 2024 | -1.822M |
| September 12, 2024 | -2.283M |
| September 11, 2024 | -0.6371M |
| September 10, 2024 | -2.283M |
| September 09, 2024 | -1.999M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-43.15M
Minimum
Jun 16 2022
711.12M
Maximum
Mar 04 2020
177.32M
Average
36.16M
Median
Jul 25 2023
Enterprise Value Benchmarks
| Catheter Precision Inc | 1.952M |
| AIM ImmunoTech Inc | 6.697M |
| Perspective Therapeutics Inc | 240.17M |
| Protalix BioTherapeutics Inc | 78.35M |
| Armata Pharmaceuticals Inc | 172.18M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.097M |
| Revenue (Quarterly) | 0.189M |
| Total Expenses (Quarterly) | 8.485M |
| EPS Diluted (Quarterly) | -1.23 |
| Profit Margin (Quarterly) | -4.28K% |
| Earnings Yield | -595.0% |
| Normalized Earnings Yield | -695.94 |